about
Ocular medicines in children: the regulatory situation related to clinical researchOral ondansetron versus domperidone for symptomatic treatment of vomiting during acute gastroenteritis in children: multicentre randomized controlled trial.Antidepressant and antipsychotic use in an Italian pediatric population.Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new usersMethods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies.Seasonal influenza immunization in early infancy?Drug use profile in outpatient children and adolescents in different Italian regionsChildhood asthma management pre- and post-incident asthma hospitalization.Inappropriate use of anti-asthmatic drugs in the Italian paediatric population.Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries.Oral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double Blind Randomized Controlled TrialPostnatal depression screening in a paediatric primary care setting in Italy.The epidemiology of psychotropic drug use in children and adolescents.Geographical epidemiology of antibacterials in the preschool age.Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis.Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005.Drug prescriptions to outpatient children: a review of the literature.Adverse drug reactions in childhood: a review of prospective studies and safety alerts.Psychotropic drug use during breastfeeding: a review of the evidence.Drug prescribing by Italian family paediatricians: an exception?Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period.Pain management in the paediatric population: the regulatory situation in Europe.Differences in antibiotic prescribing in paediatric outpatients.Antipsychotic drug toxicology in children.Safety of medicines used for ADHD in children: a review of published prospective clinical trials.Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.Review of Italian primary care paediatricians identifies 38 commonly prescribed drugs for children.International trends in clozapine use: a study in 17 countries.Antiepileptic drug use in Italian children over a decade.Drugs Delivery by Charities: A Possible Epidemiologic Indicator in Children of Undocumented Migrants.Emergency department visits in older people: pattern of use, contributing factors, geographical differences and outcomes.Psychotropic medicine prescriptions in Italian youths: a multiregional study.Serological screening for celiac disease in a northern Italian child and adolescent population after the onset of type 1 diabetes: a retrospective longitudinal study of a 7-year period.Increase in non-evidence based use of antidepressants in children is cause for concern.Burden of psychiatric disorders in the pediatric population.Anti-asthmatic drug prescriptions to an Italian paedriatic population.Pregnancy outcome after cabergoline treatment in early weeks of gestation.Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.Differences in outpatient antibiotic prescription in Italy's Lombardy region.More and better should be done to guarantee evidence-based management of ADHD in children across Europe.
P50
Q27027227-9A747938-C54D-4185-88C3-2538B6A2534FQ33817527-05BA8A63-AC54-4233-8001-94C94C53387DQ33909185-7D8FE0E5-E6DB-4975-AA80-B02353EF2AFEQ34049548-BA096962-A06B-4E8B-B0F3-60C65166F388Q34351816-56914F0C-FAF4-46AE-BBD5-3628A9F02872Q34445842-31C7253E-3442-4E54-83FE-4E9A8B89B166Q34655463-EFAD3150-A5EA-46B7-99B9-3A9E455AD82AQ35034685-36D80A02-74C7-4988-9E1F-C65B833D63CEQ35298574-25377550-C18E-4242-A5C2-63B4BBEE9A97Q35629797-C7498B76-491A-461C-9CB6-5EA026F019EDQ36202546-77847A06-6E7B-40B3-A99B-21E6F62988BFQ36260159-49618A48-2121-475F-A424-295BA83C93AAQ36272506-9EB2E2DA-3E72-4B33-939C-1429DA4B08FEQ36517570-23C603FB-280D-459F-AE47-35510FC4C508Q36896164-CA9F9855-B6DE-44AC-86A9-B6B0599AA38EQ36949944-1B1F0ED8-94EB-4126-A33F-B182E66773D8Q37520736-CA2979C5-2549-4BE5-A724-F3A0B20BF002Q37521364-CC2FA75D-DA03-4DDC-A5ED-E2996784F453Q37593393-C64AC2EE-DD47-489E-9918-60507913C244Q37677802-1E1E667F-8A52-4FD5-B8D8-525553A651E9Q37763638-9AC01915-8E1C-4F66-95A0-E3DD7D55BC31Q37768286-FC49B4B5-FEBC-4AA8-95A2-6F8EC94D35B6Q37828298-B5285ECB-39BA-4E59-A570-8DACF5F046FAQ37852719-F662D608-56F5-4B3D-87C9-2DA35CC74BF7Q38205749-7F5C877A-8A76-4CCD-846F-4539E7844B11Q38243242-ABF8CBB7-CF62-42C1-8C9C-8596812CE633Q38244068-39758EC6-325F-4B82-9BA2-59F16D1BD9B4Q38684191-DAE9D4F8-87ED-4F5A-A4A9-E49353ADEC3AQ39151495-A49C58CD-90F1-49A2-9C9E-256EFC9B60C9Q39558223-0C2F15C7-72FE-4740-9418-651775873A3FQ39956455-E413D854-064C-4B64-A6A4-C1E6F1218F4AQ40897841-5846FB76-303C-4912-85A8-747A60EEAD63Q40923558-BE6B5972-C477-4930-87C4-301319CE6EC4Q43204468-D46DEAD3-4ADF-48F5-9977-88042BE26E64Q43561162-C6A79A09-300F-435D-94D8-803F7C0A0D96Q43640035-5B44C495-FE65-4D62-9006-74E16F75AECCQ44195068-ECAD15BE-DDBF-417C-9ADD-FCF597043D18Q44611803-D82CD050-6E56-4B3D-85D1-52A4D5B48BFFQ44723434-434E7D23-C252-4AB3-AA09-2438C2EAB6C3Q45422010-6E7F26D3-A974-41C9-A058-07A38EB0BFE6
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Clavenna
@ast
Antonio Clavenna
@en
Antonio Clavenna
@es
Antonio Clavenna
@nl
type
label
Antonio Clavenna
@ast
Antonio Clavenna
@en
Antonio Clavenna
@es
Antonio Clavenna
@nl
prefLabel
Antonio Clavenna
@ast
Antonio Clavenna
@en
Antonio Clavenna
@es
Antonio Clavenna
@nl
P106
P21
P31
P496
0000-0001-5536-4192